Female Pelvic Med Reconstr Surg

• 

  Publication Venue For

  • Design of a 3-Arm Randomized Trial for Posthysterectomy Vault Prolapse Involving Sacral Colpopexy, Transvaginal Mesh, and Native Tissue Apical Repair: The Apical Suspension Repair for Vault Prolapse in a Three-Arm Randomized Trial..  26:415-424. 2020
  • Response to "Intraurethral Lidocaine Use During Urodynamic Testing Deserves Further Study"..  26:465. 2020
  • Design of a Study to Measure Patient-Perspectives in Adverse Event Reporting (the PPAR Study): Supplementary Study to the ASPIRe Trial. 2020
  • Deciding Our Future: Consensus Conference Summary Report..  26:159-161. 2020
  • The Design of a Prospective Trial to Evaluate the Role of Preoperative Frailty Assessment in Older Women Undergoing Surgery for the Treatment of Pelvic Organ Prolapse: The FASt Supplemental Trial. 2020
  • Does a Recent Urinary Tract Infection Increase the Risk of Postprocedure Urinary Tract Infection After Onabotulinum Toxin A? 2019
  • Reliability of Symptoms and Dipstick for Postoperative Catheter-Associated Urinary Tract Infections. 2019
  • Does Mesh Weight Affect Time to Failure After Robotic-Assisted Laparoscopic Sacrocolpopexy? 2018
  • Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor Disorders. 2017
  • Cost-Effectiveness Analysis of Anticholinergics Versus Botox for Urgency Urinary Incontinence: Results From the Anticholinergic Versus Botox Comparison Randomized Trial..  22:311-316. 2016
  • Urinary Incontinence and Health-Seeking Behavior Among White, Black, and Latina Women..  22:340-345. 2016
  • Breakdown of Perineal Laceration Repair After Vaginal Delivery: A Case-Control Study..  22:276-279. 2016
  • The Design of a Randomized Trial of Vaginal Surgery for Uterovaginal Prolapse: Vaginal Hysterectomy With Native Tissue Vault Suspension Versus Mesh Hysteropexy Suspension (The Study of Uterine Prolapse Procedures Randomized Trial)..  22:182-189. 2016
  • Building a National Registry for Pelvic Organ Prolapse..  22:61-62. 2016
  • Pelvic Floor Disorders Registry: Study Design and Outcome Measures..  22:70-76. 2016
  • The Pelvic Floor Disorders Registry: Purpose and Development..  22:77-82. 2016
  • Ultrasound Evaluation of the Urethra and Bladder Neck Before and After Transurethral Bulking..  22:118-122. 2016
  • Adherence to Oral Therapy for Urgency Urinary Incontinence: Results from the Anticholinergic Versus Botox Comparison (ABC) Trial..  22:24-28. 2016
  • Incidence and Predictors of Anal Incontinence After Obstetric Anal Sphincter Injury in Primiparous Women..  21:182-189. 2015
  • Barriers to urinary incontinence care seeking in White, Black, and Latina women..  21:83-86. 2015
  • Discrepancies in the female pelvic medicine and reconstructive surgeon workforce..  21:99-105. 2015
  • Symptom improvement in women after fecal incontinence treatments: a multicenter cohort study of the pelvic floor disorders network..  21:46-52. 2015
  • Minimum important differences for scales assessing symptom severity and quality of life in patients with fecal incontinence..  20:342-348. 2014
  • Psychosocial factors related to the use of InterStim® for the treatment of refractory overactive bladder..  20:272-275. 2014
  • What happens to the posterior compartment and bowel symptoms after sacrocolpopexy? evaluation of 5-year outcomes from E-CARE..  20:261-266. 2014
  • How does site of pelvic organ prolapse repair affect overactive bladder symptoms?.  20:203-207. 2014
  • Perioperative anticholinergic medications and risk of catheterization after urogynecologic surgery..  20:163-167. 2014
  • Is postoperative bowel function related to posterior compartment prolapse repair?.  20:90-94. 2014
  • Neuroanatomy, neurophysiology, and dysfunction of the female lower urinary tract: a review..  20:65-75. 2014
  • The impossible voyage..  20:1-6. 2014
  • Sexual function before and after non-surgical treatment for stress urinary incontinence..  17:30-35. 2011
  • Prevalence and incidence of urinary incontinence in a diverse population of women with noncancerous gynecologic conditions..  16:284-289. 2010
  • American Urogynecologic Society Prolapse Consensus Conference Summary Report..  24:260-263.
  • Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model..  22:467-471.
  • Concomitant Anterior Repair, Preoperative Prolapse Severity, and Anatomic Prolapse Outcomes After Vaginal Apical Procedures..  25:22-28.
  • Irritable Bowel Syndrome and Quality of Life in Women With Fecal Incontinence..  23:179-183.
  • Long-Term Effectiveness of Uterosacral Colpopexy and Minimally Invasive Sacral Colpopexy for Treatment of Pelvic Organ Prolapse..  23:188-194.
  • Peer Reviewers Are Our Strength..  23:169.
  • Randomized Controlled Trial to Assess the Impact of Intraurethral Lidocaine on Urodynamic Voiding Parameters..  25:265-270.
  • Resident Knowledge, Surgical Skill, and Confidence in Transobturator Vaginal Tape Placement: The Value of a Cadaver Laboratory..  23:392-400.
  • Same-Day Discharge After Robotic-Assisted Sacrocolpopexy..  25:337-341.
  • Summary: 2017 International Consultation on Incontinence Evidence-Based Surgical Pathway for Pelvic Organ Prolapse..  26:30-36.
  • The Incidence of Perioperative Adverse Events in the Very Elderly Undergoing Urogynecologic Surgery..  22:425-429.
  • Urine RNA Processing in a Clinical Setting: Comparison of 3 Protocols..  25:247-251.
  • Vaginal Uterosacral Ligament Suspension: A Retrospective Cohort of Absorbable and Permanent Suture Groups..  24:207-212.
  • Ultrasound Evaluation of Midurethral Sling Position and Correlation to Physical Examination and Patient Symptoms. 2015
  • The Quality of Health Information Available on the Internet for Patients With Pelvic Organ Prolapse. 2015